The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results of efficacy and tolerability of first-line bevacizumab in combination with carboplatin/paclitaxel in patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer in clinical practice - a German cohort study.
 
Alexander Mustea
Consulting or Advisory Role - Roche Pharma AG
 
Sven Mahner
No Relationships to Disclose
 
Gülten Oskay-Özcelik
No Relationships to Disclose
 
Pauline Wimberger
No Relationships to Disclose
 
Peter Jungberg
No Relationships to Disclose
 
Wolfgang Meinerz
No Relationships to Disclose
 
Dietmar Reichert
No Relationships to Disclose
 
Helmut Forstbauer
No Relationships to Disclose
 
Maren Keller
No Relationships to Disclose
 
Rolf Richter
No Relationships to Disclose
 
Melanie Frank
No Relationships to Disclose
 
Sandra Klawitter
Employment - Roche Pharma AG
 
Claudia Kiewitz
Employment - Roche Pharma AG
 
Marianne Mueller
No Relationships to Disclose
 
Jalid Sehouli
No Relationships to Disclose